Structure and Replication of Yeast Prions  by Kushnirov, Vitaly V & Ter-Avanesyan, Michael D
Cell, Vol. 94, 13±16, July 10, 1998, Copyright 1998 by Cell Press
Structure and Replication Minireview
of Yeast Prions
upon overexpression of the Sup35 and Ure2 proteins
(Ure2p), respectively (Chernoff et al., 1993; Wickner,
1994). The [PSI1] and [URE3] have the same phenotypes
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as recessive (loss-of-function) mutations in the SUP35Moscow 121552
and URE2 genes: [PSI1] enhances suppression of non-Russia
sense mutations, and [URE3] prevents the nitrogen-
dependent repression of the ureidosuccinate utilization
pathway. To explain the inheritance of these determi-
nants, Wickner (1994) has suggested that Sup35p and
Although prion-like phenomena in yeast were discov-
Ure2p may use a prion-like autocatalytic mechanism to
ered fairly recently, the remarkably rapid progress in
switch into an alternative conformational and functional
their studies promises that they may become a helpful state, resulting in [PSI1] or [URE3] phenotypes. This
model for the understanding of prions in general. The suggestion, originally based on genetic evidence, has
yeast system may be particularly suitable for studying
quickly received biochemical support. It was demon-
fundamental properties of prions common between
strated that the properties of Sup35p in [PSI1] cells
yeast and mammals, such as the structure of prions and (Sup35pPSI1) are altered and similar to that of PrPSc: Sup-
the way they replicate. 35pPSI1 shows increased protease resistance and is
Little is known about additional proteins participating found mostly in an aggregated state (Patino et al., 1996;
in prion conversion in mammals. In yeast, the propaga- Paushkin et al., 1996). An increased protease resistance
tion of the [PSI1] prion determinant critically depends was also shown for Ure2p from [URE3] cells. These
on the chaperone protein Hsp104 (Hsp104p). This de- results indicate that the formation of high±molecular
pendence is somewhat paradoxical: both the lack and weight aggregates and protease resistance are charac-
the excess of Hsp104p eliminate [PSI1]. Below we pre- teristic, rather than fortuitous, properties of different
sent a model explaining the role of Hsp104p in propaga- prions.
tion of the prion structure of the yeast Sup35 protein Only the amino-terminal fragment of 113 amino acids
(Sup35p). This model may have implications for the re- (N domain) is required for Sup35p aggregation and
lated mammalian diseases. [PSI1] propagation (Paushkin et al., 1996). The carboxy-
The Prion Concept terminal domain of amino acids 254±685 is responsible
The prion concept originates from studies of transmissi- for the Sup35p function in translation termination. In
ble spongiform encephalopathies, such as sheep scrapie [PSI1] cells, Sup35p aggregates via its N domain, which
and human kuru and Creutzfeldt-Jacob disease (CJD) reduces the efficiency of translation termination and
(for review, see Prusiner, 1991; Horwich and Weissman, causes the nonsense-suppressor phenotype. Thus, the
1997). Numerous lines of evidence indicate that the in- N domain can serve in a [PSI1]-dependent regulation of
fectious agents causing these diseases are proteins the efficiency of termination. Ure2p structurally resem-
rather than nucleic acid. To explain the protein-only in- bles Sup35p, being composed of an amino-terminal
fectivity, it was proposed that the infectious protein is [URE3]-inducing domain and a carboxy-terminal func-
able to exist in two different forms and that the infectious tional domain.
form can catalyze the conversion of the normal form The prion-like conversion of Sup35p was reproduced
into the infectious one. Such protein was purified by S. in vitro, and it was demonstrated that highly purified
Prusiner and coworkers in 1982 and named prion protein Sup35pPSI1 is able to initiate such conversion efficiently
or PrP. The normal form of PrP (PrPC) represents a mem- (Paushkin et al., 1997). Thus, in full accordance with
brane protein, constitutively expressed by host cells, the prion hypothesis, the information about the Sup35p
and the infectious form (PrPSc) can catalyze the conver- altered state is stored solely within Sup35pPSI1. The in
sion of PrPC to PrPSc in full accordance with the above vitro conversion of Sup35p proceeded much more effi-
concept. Apart from the infectivity, PrPSc differs from ciently than that of PrP in analogous experiments
PrPC physically by high protease resistance and propen- (Caughey et al., 1995). This allowed a chain of sequential
sity to aggregate. This difference results from conforma- conversion reactions to be performed using an aliquot
tional alteration of PrPSc, rather than any covalent modifi- of the previous reaction to start the next one, thus mod-
cations: PrPSc is rich in b sheet, while PrPC is almost eling in vitro the continuous propagation of the Sup35p
devoid of it. prion state.
Yeast Prions Of most importance for the present consideration
The analogy with prions was used to explain the unusual were the observations that purified recombinant Sup35p
genetic properties of two yeast determinants, [PSI1] and can assemble into uniform fibers (Glover et al., 1997;
[URE3] (for review, see Lindquist, 1997). These determi- King et al., 1997; DePace et al., 1998). These fibers were
nants show non-Mendelian, cytoplasmic inheritance. similar to amyloid fibers, showing an altered Sup35p
However, unlike other cytoplasmic factors, such as mi- conformation, rich in b sheet, and an ability to bind
tochondrial genes and viruses, they may be ªcuredº or Congo red dye. These findings underscore the relation-
eliminated during growth in the presence of low concen- ship of Sup35p to both prions and amyloidogenic pro-
trations of protein denaturant guanidine hydrochloride teins, and thus support the idea that the prion and amy-
loid phenomena are related.and can reappear without introduction of new DNA,
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Amyloid Fibers and Their Similarity with Prions would be capable of precise self-reproduction. In the
polymerization model, any of the possible alternativeAmyloids are insoluble fibrous protein deposits that ac-
cumulate in some human diseases, or amyloidoses (for conformations can be stabilized by intermolecular inter-
actions within the polymer. Besides, in this model thereview, see Kelly, 1996). Although different amyloido-
genic proteins are structurally and functionally unre- existence of many different tertiary conformations is not
strictly required: the strain difference may also resultlated, the amyloid fibrils formed by them are very similar,
being about 10 nm in width and having a characteristic from different kinds of quaternary assembly of prion
molecules into fibers. The possibility of different kindscross-b structure, in which the individual b strands are
oriented perpendicular to the axis of the fibril. Amyloids of prion proteins packing into polymers was demon-
strated in the experiments on Sup35p self-assembly incan bind Congo red, giving a characteristic birefrin-
gence in polarized light. vitro (Glover et al., 1997). The fibers with apparently
different structure were observed even within a singleThere are a number of significant similarities between
the prion and amyloid phenomena. Prion diseases are Sup35p preparation. Notably, transitions between dif-
ferent structural types were never observed within aoften accompanied by fibrous PrP deposits, which show
the properties of amyloids, an increased b sheet content single fiber, which demonstrates the stable propagation
of different structural characteristics along the length ofand the ability to bind Congo red. In turn, amyloid fibers
conform to the criteria for prion protein: the normal and the fibers.
There are also some data that do not fit well with thepolymer forms of amyloidogenic proteins are clearly dif-
ferent, and the latter can promote the polymerization of polymerization model for Sup35p in its original, non-
catalytic version from Jarrett and Lansbury. They pre-normal proteins into amyloid fibers.
Structure of Prion Aggregates dicted that the rate of fibril nucleation should be highly
dependent on the monomer concentration, being pro-There are two different models for the process of prion
conversion, which also represent two different ap- portional to the (N 2 1)th power, where N is the number
of monomers in the nuclei. A similar high degree ofproaches to the structure of prions. The heterodimer
or template-assistance model assumes that infectious concentration dependence was observed in the poly-
merization on nonamyloid fibrils of sickle-cell hemoglo-PrPSc can exist as a monomer and such a monomer
catalyzes the prion rearrangement of a PrPC molecule bin. However, the nucleation of Sup35p fibrils showed
only a first-order or even lower dependence on thethrough formation of a heterodimer complex. Then two
PrPSc molecules dissociate and can repeat the cycle, Sup35p concentration (Glover et al., 1997; DePace et
al., 1998). These data may be explained by the observa-while the PrPSc aggregation is a secondary process,
which is not essential for the prion conversion (Prusiner, tion of some metastable oligomeric Sup35p complexes
at early stages of polymerization (Glover et al., 1997).1991). The nucleated polymerizationmodel is a universal
model for the prion and amyloid formation, which con- These complexes may either represent ªoff-pathwayº
associations, and then the concentration of Sup35p mo-siders prions and amyloid fibers as regular polymers or
one-dimensional crystals that serve as nuclei for further nomers may be much lower and not proportional to its
total concentration, or they may represent some inter-polymerization (Jarrett and Lansbury, 1993). The forma-
tion of nuclei is a rate-limiting step of the process, and mediates in the nucleation process. Thus, the kinetic
data do not disprove the polymerization model, but sug-thus the presence of preformed nuclei greatly acceler-
ates polymerization. The conformational alteration of gest that the Sup35p nucleation is a more complicated
process than anticipated by Jarrett and Lansbury andmonomers may either occur spontaneously and then be
fixed in polymer structure, as originally suggested by may thus support the alternative, catalytic variant of this
model.Jarrett and Lansbury, or, alternately, be directly cata-
lyzed by polymer at the moment of accretion (Horwich The ability of Sup35p to assemble into amyloid-like
fibers in vitro argues strongly in favor of the existenceand Weissman, 1997). In both noncatalytic and catalytic
variants of this model, the arrangement of prion mole- of a polymer structure of Sup35pPSI1 in vivo. First, the
amyloid formation by Sup35p occurred under a widecules into ordered aggregates is a key characteristic of
a prion state. range of salt concentrations and pH, including those
found within yeast cells. Second, the protein extractsAlthough at present it is difficult to choose in favor of
one of these two models, it should be noted that the from [PSI1] cells were able to initiate the Sup35p poly-
merization in vitro (Glover et al., 1997). Finally, the de-polymerization model is in a better agreementwith some
sets of experimental data. For example, the scrapie creasedability of mutant Sup35p to support [PSI1] prop-
agation correlated with the decreased rate of in vitroagent was always found in aggregated fractions and
never isolated as soluble monomer. The experiments fibril formation by these proteins (DePace et al., 1998).
Taken together, the above arguments provide significanton in vitro prion conversion of either PrP or Sup35p also
showed that the converting activity was only found in support for the filamentous structure of Sup35pPSI1 ag-
gregates in vivo.the fractions of aggregates (Caugheyet al., 1995; Paush-
kin et al., 1997). The polymerization model is especially A Role for the Hsp104 Protein
The chaperone Hsp104p plays an important role in prop-attractive when considering the existence of different
prion strains. The strain variation was observed for both agation of the [PSI1] determinant. Increased levels of
Hsp104p may cause [PSI1] elimination, but surprisingly,conventional prions and [PSI1], and is thought to reflect
different conformations of the prion proteins. It is diffi- the lack of Hsp104p also cures [PSI1] (Chernoff et al.,
1995). Based on these results, two models have beencult to imagine that many different conformations can
stably exist as monomers and, moreover, that they suggested for the role of Hsp104p in propagation of the
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[PSI1] state. According to the first model: ªHsp104p is
required because it promotes a conformational `transi-
tion' state in Sup35 that facilitates its folding into the
prion-like [PSI1] structure. When Hsp104p concentra-
tions are toohigh, however, the transition state conform-
ers generated by Hsp104p are too broadly dispersed to
promote assembly into a substructure that is competent
for association with preexisting [PSI1] elementsº (Lind-
quist, 1997). Alternatively, we proposed that Hsp104p
cleaves Sup35pPSI1 aggregates into smaller pieces,
which is necessary for their stable inheritance in cellular
divisions (Paushkin et al., 1996). The demonstration that
Sup35p can form amyloid-like fibers in vitro suggests a
similar fibrous structure for the Sup35pPSI1 aggregates
in vivo. This provides additional support for the second
model, which we will discuss further below.
Figure 1. A Model for the Chaperone Hsp104p Function in Replica-
Hsp104p was not required for the polymerization of tion of Sup35p Prion Polymers
Sup35p into fibers in vitro in contrast to the strong re- By refolding Sup35p molecules at random sites of Sup35p fibers,
quirement for Hsp104p for the [PSI1] propagation in Hsp104p may cleave the fibers into shorter fragments, thus increas-
vivo. This suggests that Hsp104p is not essential for ing the number of prion particles and overall polymerization rate.
Sup35p monomers are shown as circles. It is not clear whetherthe Sup35p prion conversion, but is required for certain
polymerization occurs at one or both ends of the fiber. One-endedaspects encountered only in vivo, such as, for example,
polymerization is depicted by analogy with flagellin (Asakura, 1970).the inheritance of the prion state. It was demonstrated
that Hsp104p dissolves aggregates of heat-denatured
protein (Parsell et al., 1994). Overexpression of Hsp104p
polymerization rate and ensure the segregation ofin [PSI1] cells caused an increase in levels of soluble
Sup35pPSI1 aggregates in cellular divisions. It should beSup35p and a gradual decrease of aggregated Sup35p
noted that the proposed mechanism of Hsp104p action(Paushkin et al., 1996). This suggests that Hsp104p may
is only applicable to filamentous aggregates and is un-act on Sup35pPSI1 complexes in the same way as it acts
likely to work in the case of globular aggregates, whichon denatured protein aggregates. Probably, Sup35pPSI1
could not be cut so easily into smaller pieces.aggregates show some properties of denatured protein,
The acceleration of fibril formation by fragmentationin contrast to other cellular macrostructures and micro-
was observed in several cases for both amyloid and non-filaments not recognized by Hsp104p. The action of
amyloid fibrils. For example, it was found that the poly-Hsp104p on Sup35pPSI1 fibers at any random position
merization of purified Sup35p was dramatically acceler-would simply cut them into smaller pieces. This may
ated simply by rotation of the samples during incubationoccur through refolding of one or several Sup35p mole-
(DePace et al., 1998). The acceleration was explainedcules to a soluble conformation at a particular site. The
by shearing of the Sup35p fibrils by hydrodynamic forces.ªdestructiveº function of Hsp104p toward Sup35p fibers
This appears to be the most likely explanation, evenmay be balanced by their ability to grow by the accretion
though such forces in a rotating tube should be fairlyof soluble monomers. Overexpressed Hsp104p may dis-
mild.rupt the balance and dissolve all Sup35p aggregates.
Hsp104p is the only chaperone capable of disaggre-However, at moderate levels Hsp104p would only facili-
gating heat-denatured proteins in yeast (Parsell et al.,tate the propagation and inheritance of prion aggregates
1994). Since Hsp104p is essential for the [PSI1] mainte-due to the following considerations.
nance, one might assume that Hsp104p could be theFirst, since Sup35p filaments can grow only at their
only or the most efficient enzyme capable of breakingends, the overall polymerization rate is proportional to
filamentous aggregates and that this function might notthe number of these ends. The cuts by Hsp104p could
be substituted by other cellular enzymes, such as othercreate new free ends, thus accelerating polymerization
chaperones or proteases.(Figure 1).
Implications for Higher OrganismsSecond, it is possible that the growth surfaces of
By analogy with the yeast model, the fragmentation ofthe aggregate would become blocked due to fortuitous
prion and amyloid polymers performed by Hsp104p ho-interactions with other proteins or proteolytic fragments
mologs or other factors should influence their propaga-of the same protein. The polymerization would be con-
tion and accumulation. The fragmentation might accel-tinued only if new growth faces would be created by
erate accumulation of prion and amyloid aggregates,Hsp104p cleavage at internal sites of the fiber.
but it might also serve to dissolve these aggregates ifThird, thecleavage of Sup35p aggregates by Hsp104p
the fragmenting activity is high enough. The level ofwould be required for the inheritance of aggregates in
chaperone activitycould control the appearance of amy-frequently dividing yeast cells. Without it the aggregates
loids and explain their age-dependent onset. The frag-could grow in size, but their number would not increase,
mentation of prions would be essential for their trans-which would eventually preclude their segregation to
missibility, but would not be so critical for amyloiddaughter cells in cellular divisions.
polymers, which are not transmissible and can appearThus, although Hsp104p is not essential for the Sup35p
prion-like conversion, it could increase the overall Sup35p by nucleation.
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DePace, A.H., Santoso, A., Hillner, P., and Weissman, J.S. (1998).The different frequency of fragmentation could ex-
Cell 93, 1241±1252.plain the different properties of prions in two human
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Horwich, A.L., and Weissman, J.S. (1997). Cell 89, 499±510.PrPSc fragmentation. Another human prion disease,
Jarrett, J.T., and Lansbury, P.T. (1993). Cell 73, 1055±1058.Gerstmann-Straussler-Sheinker syndrome, is charac-
Kelly, J.W. (1996). Curr. Opin. Struct. Biol. 6, 11±17.terized by filamentous, amyloid-like PrP deposits and a
King, C.-Y., Tittmann, P., Gross, H., Gebert, R.,Aebi, M.,and Wutrich,slower disease progression than CJD. These pheno-
K. (1997). Proc. Natl. Acad. Sci. USA 94, 6618±6622.types could be related: more frequent fragmentation
Lindquist, S. (1997). Cell 89, 495±498.of CJD fibrils could mean higher overall polymerization
Parsell, D.A., Kowal, A.S., Singer, M.A., and Lindquist, S. (1994).speed and faster disease progression.
Nature 372, 475±478.In vitro, yeast Hsp104p interacted specifically with
Patino, M.M., Liu, J.-J., Glover, J.R., and Lindquist, S. (1996). Sci-Sup35p, PrP and b-amyloid 1±42 peptide (Schirmer and
ence 273, 622±626.
Lindquist, 1997), and moreover, promoted the prion con-
Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan,version of PrP (DebBurman et al., 1997). These results
M.D. (1996). EMBO J. 15, 3127±3134.
suggest that Hsp104p analogs in mammals could also
Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan,
interact with such proteins and participate in prion and M.D. (1997). Science 277, 381±383.
amyloid formation. Hsp104p is likely to occur in animals, Prusiner, S.B. (1991). Science 252, 1515±1522.
since it shows similarity to the Clp/Hsp100 family of
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach,
bacterial and eukaryotic chaperones and is functionally B., Hasenbank, R., Bates, G.P., Davies, S.W., Lehrach, H., and
conserved between yeast and plants. However, in con- Wanker, E.E. (1997). Cell 90, 549±558.
trast to yeast prions, which propagate inside cells, mam- Schirmer, E.C., and Lindquist, S. (1997). Proc. Natl. Acad. Sci. USA
malian prions and most amyloids occur extracellularly. 94, 13932±13937.
Hsp104p is not secreted in yeast and it is likely to be so Wickner, R.B. (1994). Science 264, 566±569.
in mammals as well. At least one might expect different
levels of chaperone fragmenting activity and probably
even different factors causing fragmentation in intra-
and extracellular compartments.
Thus, in terms of the type and levels of fragmenting
activity the best analogy with yeast prions may be found
in intracellular amyloid diseases, related to the expan-
sion of polyglutamine tracts in some human proteins.
These diseases are accompanied by neuronal nuclear
inclusions, formed by the respective polyglutamine pro-
teins. The expanded polyglutamine domain of one such
protein, huntingtin, was shown to form amyloid fibrils
in vitro (Scherzinger et al., 1997). The abundance of
glutamine and the related amino acid asparagine is also
a characteristic feature of prion domains of Sup35p and
Ure2p of S. cerevisiae. This feature is common for
Sup35p from different yeast species and fungi, although
not from higher eukaryotes. The importance of these
residues was further demonstrated by the finding that
the mutations which interfere with the prion properties
of Sup35p fall within a short amino-terminal fragment,
which is rich in Gln and Asn (DePace et al., 1998). The
yeast prions and polyglutamine proteins might be con-
sidered as a single structural class, in contrast to other
amyloidogenic proteins, which are not abundant in Gln
and Asn. These similarities suggest that chaperones
like Hsp104p might play an important role in diseases
associated with expanded polyglutamine tracts.
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